Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company will have one-on-one conference callwithAnalysts/Investors on Wednesday, 1stDecember2021; the details of the same are given below: Sr. no. Name Venue 1 Lucky Securities Zoom Conference Call Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.
30-11-2021
Bigul

Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulations 47 of SEBI(LODR) Regulations, 2015 the company has published the Un-Audited Financial Results for the quarter and half year ended September 30,2021 in ''Indian Express'' (English) edition dated Saturday, November 13th, 2021 & in Financials Express'' (Gujarati) edition dated Saturday, November 13th, 2021. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in the above mentioned newspapers. Kindly take the same on record and acknowledge receipt.
15-11-2021
Bigul

Themis Medicare Ltd - 530199 - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulation, 2015 ['SEBI (LODR) Regulations, 2015'] Regarding Re-Constitution/Appointment To Board Committees

 Audit & Risk Management Committee 1- Mr. Vijay Agarwal has been appointed as the Chairman of the Committee in place of Mr. Humayun Dhanrajgir who has since ceased to be a Director upon completion of his two terms of Independent Directorship. 2- Mr. Bhasker Iyer (Additional Independent Director) has been appointed as a member of the Committee. Corporate Social Responsibility Committee The Corporate Social Responsibility Committee has been re-constituted by appointing Mrs. Manjul Sandhu (Independent Director) in place of Mr. Humayun Dhanrajgir who has ceased to be a Director upon completion of his two terms of Independent Directorship . Stakeholders Relationship Committee Stakeholders Relationship Committee has been re- constituted by appointing Mrs. Manjul Sandhu (Independent Director) and Mr. Bhasker Iyer (Additional Independent Director) as members thereof. Kindly take the same on record.
12-11-2021
Bigul

Themis Medicare Ltd - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received the below mentioned intimation / request for Loss of Share Certificate / issuance of duplicate share certificate from the following shareholder: Name Folio No. Cert. No. Number of Shares Dist. No. From Dist. No. To PINKI JAYSWAL 00004108 6442 100 3360101 3360200 We shall issue the duplicate Share Certificate only after the necessary formalities are carried out by the Shareholder. This may be taken as compliance under the Listing Regulations.
12-11-2021
Bigul

Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Change in Directorate

 2. Appointment of Mr. BhaskerVembanIyer(DIN : 00480341) as an Additional Independent Director with effect from 12th November,2021. 3. Re-appointment of Dr. Dinesh S. Patel (DIN : 00033273)Executive Vice Chairman of the Company,whose current term will be ending on 13th February, 2022,, whose current term will be ending on 13th February, 2022. 4. Re-appointment of Dr.Sachin D. Patel(DIN : 00033353)as Managing Director & CEO of the Company,whose current term will be ending on 13th February, 2022.
12-11-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Results- Financial Results For September 30,2021(Quarter And Half Year Ended)

 1. Approved the Unaudited Standalone and Consolidated financial results for the Quarter and HalfYear ended 30th September, 2021.A copy of theUnaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2021 2. Appointment of Mr. BhaskerVembanIyer(DIN : 00480341) as an Additional Independent Director 3. Re-appointment of Dr. Dinesh S. Patel (DIN : 00033273)Executive Vice Chairman of the Company,whose current term will be ending on 13th February, 2022,, whose current term will be ending on 13th February, 2022. 4. Re-appointment of Dr.Sachin D. Patel(DIN : 00033353)as Managing Director & CEO of the Company,whose current term will be ending on 13th February, 2022. The Board has re-appointed him as Managing Director & CEO for further period of 5 years with effect from 14th February,2022subject to approval by the shareholders.( Annexure IV)
12-11-2021
Bigul

Themis Medicare Ltd - 530199 - Board Meeting Outcome for Outcome Of Board Meeting For The Unaudited Financial Results For Quarter And Half Year Ended 30.09.2021

 1. Approved the Unaudited Standalone and Consolidated financial results for the Quarter and HalfYear ended 30th September, 2021.A copy of Financial Results for the Quarter and Half Year ended 30th September, 2021 is enclosed herewith. Also attached financial result highlight 2. Appointment of Mr. BhaskerVembanIyer(DIN : 00480341) as an Additional Independent Director . 3. Re-appointment of Dr. Dinesh S. Patel (DIN : 00033273)Executive Vice Chairman of the Company,whose current term will be ending on 13th February, 2022,, whose current term will be ending on 13th February, 2022. During the tenure of his reappointment he will be completing 75 years of age. The Board also approved his continuation as Director and Executive Vice Chairman beyond the age of 75 years subject to the approval of the Shareholders. 4. Re-appointment of Dr.Sachin D. Patel(DIN : 00033353)as Managing Director & CEO of the Company,whose current term will be ending on 13th February, 2022.
12-11-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Intimation Of Date Of Board Meeting & Closure Of Trading Window

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Friday, 12th November, 2021 inter alia, to consider, the Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended on 30th September, 2021. Further, in continuation of our Letter dated 29th September 2021, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Friday, 1stOctober, 2021, which shall remain closed till the closure of trading hours on 14th November, 2021 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results as per the policy for prohibition of Insider Trading ("the Code") adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time. This is for your information and record.
02-11-2021
Bigul

Themis Medicare Ltd - 530199 - Shareholding for the Period Ended September 30, 2021

 Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
12-10-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended September 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
11-10-2021
Next Page
Close

Let's Open Free Demat Account